![](https://investorshub.advfn.com/uicon/716239.png?cb=1669318942)
Thursday, April 20, 2023 2:43:36 PM
April 20, 2023 07:30 ET | Source: GBT Technologies Inc.
The patent will be granted on May 2, 2023, and protecting AI based sophisticated, electronic health device
SAN DIEGO, April 20, 2023 (GLOBE NEWSWIRE) -- GBT Technologies Inc. (OTC PINK: GTCH) ("GBT”, or the “Company”) announced that it received a noticed issue and will be granted on May 2, 2023, U.S. patent number 11,638,523, covering its machine learning-driven, human vitals device, non-provisional patent application, qTerm non-provisional patent was filed on August 3, 2020, describing an intelligent, electronic health device to measure human vitals with a touch of a finger, which was assigned qTerm as an internal project name. GBT successfully completed the development of a fully working prototype in 2022 including robust testing, debugging and a participant study. qTerm’s first release measures body temperature, blood oxygen and heart rate vitals. Future releases are planned to include blood pressure measurement and enhanced, AI-driven analytics. The device is accompanied by a smartphone mobile app and synchronized web application to keep measurement history and provide analytics for user's records at a later phase. The web and mobile applications also enable direct access to user’s data anywhere around the world, enabling efficient, remote telemedicine capabilities. Upon user’s permission, a user’s body temperature and location can be anonymously shared with other users to provide health risk proximity alerts. The patent describes advanced AI technology to perform on-going vitals monitoring and analytics, providing personal health related notifications and alerts. GBT plans to file a continuation patent for qTerm, further strengthening the underlying intellectual property concepts. For more information visit qTerm™ | Vital Signs Al Device.
About Us
GBT Technologies, Inc. (OTC PINK: GTCH) (“GBT”) (http://gbtti.com) is a development stage company which considers itself a native of Internet of Things (IoT), Artificial Intelligence (AI) and Enabled Mobile Technology Platforms used to increase IC performance. GBT has assembled a team with extensive technology expertise and is building an intellectual property portfolio consisting of many patents. GBT’s mission, to license the technology and IP to synergetic partners in the areas of hardware and software. Once commercialized, it is GBT’s goal to have a suite of products including smart microchips, AI, encryption, Blockchain, IC design, mobile security applications, database management protocols, with tracking and supporting cloud software (without the need for GPS). GBT envisions this system as a creation of a global mesh network using advanced nodes and super performing new generation IC technology. The core of the system will be its advanced microchip technology; technology that can be installed in any mobile or fixed device worldwide. GBT’s vision is to produce this system as a low cost, secure, private-mesh-network between all enabled devices. Thus, providing shared processing, advanced mobile database management and sharing while using these enhanced mobile features as an alternative to traditional carrier services.
https://www.globenewswire.com/news-release/2023/04/20/2650869/0/en/GBT-s-intelligent-human-vitals-qTerm-device-patent-received-an-issue-notification.html
Don't invest what you can't afford to lose. Always do your own DD. INV4$
Recent GTCH News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/20/2024 08:06:02 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 05/14/2024 08:10:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/19/2023 09:32:06 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:16:00 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 09:07:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/07/2023 09:07:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/06/2023 09:06:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/17/2023 08:06:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/28/2023 10:04:19 AM
- Form DEF 14C - Other definitive information statements • Edgar (US Regulatory) • 08/23/2023 10:01:08 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/21/2023 12:00:57 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/17/2023 10:15:52 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/16/2023 11:19:14 AM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/15/2023 08:05:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/11/2023 08:05:52 PM
- Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 07/28/2023 08:05:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/21/2023 08:05:43 PM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM